$17.75
0.31[1.78%]
At close: Apr 17
$17.75
0[0.00%]
PreMarket: 4:37PM EDT
MediWound
(NASDAQ:MDWD)MediWound Stock (NASDAQ:MDWD), Analyst Ratings, Price Targets, Predictions
MediWound Ltd has a consensus price target of $19.71, established from looking at the 19 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on March 22, 2024, January 16, 2024, and November 22, 2023. With an average price target of $27.33 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 53.99% upside for MediWound Ltd from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Oppenheimer
Cowen & Co.
Maxim Group
Wells Fargo
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for MediWound
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/22/2024 | MDWD | Buy Now | MediWound | $17.75 | 57.75% | HC Wainwright & Co. | Swayampakula Ramakanth | → $28 | Reiterates | Buy → Buy | Get Alert |
| 01/16/2024 | MDWD | Buy Now | MediWound | $17.75 | 57.75% | HC Wainwright & Co. | Swayampakula Ramakanth | $26 → $28 | Maintains | Buy | Get Alert |
| 11/22/2023 | MDWD | Buy Now | MediWound | $17.75 | 46.48% | HC Wainwright & Co. | Swayampakula Ramakanth | → $26 | Reiterates | Buy → Buy | Get Alert |
| 09/21/2023 | MDWD | Buy Now | MediWound | $17.75 | 46.48% | HC Wainwright & Co. | Swayampakula Ramakanth | $23 → $26 | Maintains | Buy | Get Alert |
| 08/17/2023 | MDWD | Buy Now | MediWound | $17.75 | 102.82% | Oppenheimer | Francois Brisebois | $63 → $36 | Maintains | Outperform | Get Alert |
| 08/17/2023 | MDWD | Buy Now | MediWound | $17.75 | 29.58% | HC Wainwright & Co. | Swayampakula Ramakanth | → $23 | Reiterates | Buy → Buy | Get Alert |
| 05/31/2023 | MDWD | Buy Now | MediWound | $17.75 | 254.93% | Oppenheimer | Francois Brisebois | → $63 | Reiterates | Outperform → Outperform | Get Alert |
| 05/31/2023 | MDWD | Buy Now | MediWound | $17.75 | 29.58% | HC Wainwright & Co. | Swayampakula Ramakanth | → $23 | Reiterates | Buy → Buy | Get Alert |
| 03/17/2023 | MDWD | Buy Now | MediWound | $17.75 | 29.58% | HC Wainwright & Co. | Swayampakula Ramakanth | → $23 | Reiterates | → Buy | Get Alert |
| 01/04/2023 | MDWD | Buy Now | MediWound | $17.75 | 29.58% | HC Wainwright & Co. | Swayampakula Ramakanth | $5.5 → $23 | Maintains | Buy | Get Alert |
| 12/30/2022 | MDWD | Buy Now | MediWound | $17.75 | 40.85% | Cowen & Co. | Joshua Jennings | $6 → $25 | Maintains | Outperform | Get Alert |
| 12/22/2022 | MDWD | Buy Now | MediWound | $17.75 | 40.85% | Maxim Group | Michael Okunewitch | → $25 | Initiates | → Buy | Get Alert |
| 12/21/2022 | MDWD | Buy Now | MediWound | $17.75 | 254.93% | Oppenheimer | Francois Brisebois | $9 → $63 | Maintains | Outperform | Get Alert |
| 11/16/2022 | MDWD | Buy Now | MediWound | $17.75 | -69.01% | HC Wainwright & Co. | Swayampakula Ramakanth | $42 → $38.5 | Maintains | Buy | Get Alert |
| 07/18/2022 | MDWD | Buy Now | MediWound | $17.75 | -60.56% | Oppenheimer | Francois Brisebois | → $49 | Assumes | → Outperform | Get Alert |
| 05/18/2022 | MDWD | Buy Now | MediWound | $17.75 | -54.93% | Wells Fargo | Jacob Hughes | $49 → $56 | Maintains | Overweight | Get Alert |
| 03/21/2022 | MDWD | Buy Now | MediWound | $17.75 | -60.56% | Aegis Capital | Nathan Weinstein | $63 → $49 | Maintains | Buy | Get Alert |
| 08/17/2021 | MDWD | Buy Now | MediWound | $17.75 | -49.3% | Aegis Capital | — | — | Maintains | Buy | Get Alert |
| 08/11/2021 | MDWD | Buy Now | MediWound | $17.75 | -63.38% | HC Wainwright & Co. | Swayampakula Ramakanth | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for MediWound (MDWD)?
The latest price target for MediWound (NASDAQ: MDWD) was reported by HC Wainwright & Co. on March 22, 2024. The analyst firm set a price target for $28.00 expecting MDWD to rise to within 12 months (a possible 57.75% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MediWound (MDWD)?
The latest analyst rating for MediWound (NASDAQ: MDWD) was provided by HC Wainwright & Co., and MediWound reiterated their buy rating.
When was the last upgrade for MediWound (MDWD)?
There is no last upgrade for MediWound.
When was the last downgrade for MediWound (MDWD)?
There is no last downgrade for MediWound.
When is the next analyst rating going to be posted or updated for MediWound (MDWD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MediWound, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MediWound was filed on March 22, 2024 so you should expect the next rating to be made available sometime around March 22, 2025.
Is the Analyst Rating MediWound (MDWD) correct?
While ratings are subjective and will change, the latest MediWound (MDWD) rating was a reiterated with a price target of $0.00 to $28.00. The current price MediWound (MDWD) is trading at is $17.75, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.